Being aware of the seriousness of aGVHD shouldn't make it more likely that medical practitioners will grasp at unproven treatments.. The problem with your claim is that Remestemcel hasn't provided high quality evidence of "offering the greatest chance of survival... to what is available now". If that evidence was available, the FDA would have approved it on the first submission of the BLA.
banter and General Discussion, page-6803
-
- There are more pages in this discussion • 5,454 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |